Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Union Minister inaugurated a DST-funded Central Instrumentation Facility and three new research clusters focused on advanced materials, clean energy, and healthcare at IIT Gandhinagar
Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.
The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer
The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Subscribe To Our Newsletter & Stay Updated